United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 322,802 | 289,403 | 289,017 | 302,225 | 280,606 |
| Cost of Goods | 38,709 | 30,600 | 38,778 | 30,716 | 32,320 |
| Gross Profit | 284,093 | 258,803 | 250,239 | 271,509 | 248,286 |
| Operating Expenses | 108,482 | 43,263 | 279,508 | 167,576 | 126,302 |
| Operating Income | 176,320 | 216,140 | -28,491 | 104,649 | 122,304 |
| Interest Expense | 4,746 | 4,610 | 4,562 | 4,540 | 4,520 |
| Other Income | 1,459 | 1,686 | 1,423 | 1,070 | 735 |
| Pre-tax Income | 173,033 | 213,216 | -31,630 | 101,179 | 118,519 |
| Income Tax | 61,181 | 75,692 | -1,316 | 38,494 | 38,655 |
| Net Income Continuous | 111,852 | 137,524 | -30,314 | 62,685 | 79,864 |
| Net Income | $111,852 | $137,524 | $-30,314 | $62,685 | $79,864 |
| EPS Basic Total Ops | 2.35 | 2.73 | -0.60 | 1.25 | 1.60 |
| EPS Basic Continuous Ops | 2.35 | 2.73 | -0.61 | 1.25 | 1.60 |
| EPS Diluted Total Ops | 2.10 | 2.43 | -0.60 | 1.17 | 1.52 |
| EPS Diluted Continuous Ops | 2.10 | 2.43 | -0.60 | 1.17 | 1.52 |
| EBITDA(a) | $188,612 | $228,574 | $-16,114 | $116,510 | $134,173 |